World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
26015
World Ranking
16061
National Ranking
8085

Overview

Robert E. Reiter is affiliated with the University of California, Los Angeles in the United States. Their research primarily focuses on medicine, with significant work in pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, cancer research, oncology, and radiation.

The scientist's publication record includes frequent contributions to several venues, such as:

  • Journal of Clinical Oncology
  • The Journal of Urology
  • International Journal of Radiation Oncology*Biology*Physics
  • European Urology
  • Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition

Recent papers published by Robert E. Reiter include:

  • "Prostate cancer," published in 2021 in Nature Reviews Disease Primers
  • "NCCN Guidelines Insights: Prostate Cancer, Version 1.2021," published in 2021 in Journal of the National Comprehensive Cancer Network
  • "Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology," published in 2023 in Journal of the National Comprehensive Cancer Network
  • "Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019," published in 2020 in European Urology
  • "The DNA methylation landscape of advanced prostate cancer," published in 2020 in Nature Genetics

Their frequent collaborators include:

  • Matthew B. Rettig
  • Jérémie Calais
  • Nicholas G. Nickols
  • Michael L. Steinberg
  • Amar U. Kishan

Key topics of Robert E. Reiter's work cover:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Radiopharmaceutical Chemistry and Applications
  • Cancer, Lipids, and Metabolism
  • Advanced Radiotherapy Techniques
  • Urologic and reproductive health conditions
  • Cancer Immunotherapy and Biomarkers

Best Publications

  • Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer

    Robert E. Reiter;Zhennen Gu;Tetsuro Watabe;George Thomas

  • Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

    Young E. Whang;Xinyi Wu;Hiroyoshi Suzuki;Robert E. Reiter

  • Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.

    David A. Quigley;Ha X. Dang;Shuang G. Zhao;Paul Lloyd

  • Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial

    Wolfgang P Fendler;Wolfgang P Fendler;Jeremie Calais;Matthias Eiber;Matthias Eiber;Robert R Flavell

  • Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.

    Gu Z;Thomas G;Yamashiro J;Shintaku Ip

  • Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice.

    Karen A. Klein;Robert E. Reiter;James Redula;Hamid Moradi

  • Multifocality and Prostate Cancer Detection by Multiparametric Magnetic Resonance Imaging: Correlation with Whole-mount Histopathology

    Jesse D. Le;Nelly Tan;Eugene Shkolyar;David Y. Lu

  • Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT

    Matthias Eiber;Matthias Eiber;Ken Herrmann;Jeremie Calais;Boris Hadaschik

  • Value of Targeted Prostate Biopsy Using Magnetic Resonance–Ultrasound Fusion in Men with Prior Negative Biopsy and Elevated Prostate-specific Antigen

    Geoffrey A. Sonn;Edward Chang;Shyam Natarajan;Daniel J. Margolis

  • 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.

    Jeremie Calais;Francesco Ceci;Francesco Ceci;Matthias Eiber;Matthias Eiber;Thomas A Hope

  • Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies

    Christopher P. Filson;Shyam Natarajan;Daniel J.A. Margolis;Jiaoti Huang

  • Prostate cancer, version 1.2021: Featured updates to the nccn guidelines

    Edward Schaeffer;Sandy Srinivas;Emmanuel S. Antonarakis;Andrew J. Armstrong

  • Evidence for Clonal Outgrowth of Androgen-independent Prostate Cancer Cells from Androgen-dependent Tumors through a Two-Step Process

    Noah Craft;Chloe Chhor;Chris Tran;Arie Belldegrun

  • Discovery of New Markers of Cancer through Serial Analysis of Gene Expression Prostate Stem Cell Antigen Is Overexpressed in Pancreatic Adenocarcinoma

    Pedram Argani;Christophe Rosty;Robert E. Reiter;Robb E. Wilentz

  • Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer

    Alexander W Wyatt;Matti Annala;Rahul Aggarwal;Kevin Beja

  • Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance

    Hiroshi Tanaka;Evelyn Kono;Chau P Tran;Hideyo Miyazaki

  • LOW P27 EXPRESSION PREDICTS POOR DISEASE-FREE SURVIVAL IN PATIENTS WITH PROSTATE CANCER

    Ronald M. Yang;John Naitoh;Michael Murphy;He-Jing Wang

  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019[Formula presented]

    Silke Gillessen;Gerhardt Attard;Tomasz M. Beer;Himisha Beltran

  • Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.

    Amar U. Kishan;Ryan R. Cook;Jay P. Ciezki;Ashley E. Ross

  • CLINICAL AND GENETIC CHARACTERIZATION OF PHEOCHROMOCYTOMA IN VON HIPPEL-LINDAU FAMILIES: COMPARISON WITH SPORADIC PHEOCHROMOCYTOMA GIVES INSIGHT INTO NATURAL HISTORY OF PHEOCHROMOCYTOMA

    McCLELLAN M. Walther;Robert Reiter;Harry R. Keiser;Peter L. Choyke

Frequent Co-Authors

Jiaoti Huang
Jiaoti Huang Duke University
Anna M. Wu
Anna M. Wu City Of Hope National Medical Center
Martin E. Gleave
Martin E. Gleave University of British Columbia
Eric J. Small
Eric J. Small University of California, San Francisco
Owen N. Witte
Owen N. Witte University of California, Los Angeles
Tomasz M. Beer
Tomasz M. Beer Oregon Health & Science University
George Thomas
George Thomas Oregon Health & Science University
Christopher P. Evans
Christopher P. Evans University of California, Davis
Johannes Czernin
Johannes Czernin University of California, Los Angeles
Kim N. Chi
Kim N. Chi BC Cancer Agency

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in Medicine opens up a wide variety of roles beyond becoming a physician. For those interested in healthcare leadership, pursuing a degree in healthcare administration can fast-track you toward management positions in hospitals, clinics, and other medical organizations.

Registered nurses seeking advanced roles might consider adn to msn bridge programs, which offer a flexible path to earn a master’s degree and move into leadership, research, or teaching positions.

If you’re passionate about food, wellness, and preventative care, earning a nutritionist online degree can prepare you for a career in nutrition counseling, community health, or even sports nutrition.

Those aiming for top-tier administrative roles may want to explore cahme accredited online mha programs, ensuring a strong, accredited foundation for high-level positions in healthcare management.

These online degrees and bridge programs offer flexibility and convenience, helping you advance your career in the expanding field of healthcare—whether in administration, nursing, or nutrition.

Best Scientists Citing Robert E. Reiter

Trending Scientists